4//SEC Filing
Gelder Mark S. MD 4
Accession 0001179110-21-006842
CIK 0001130598other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:46 PM ET
Size
5.4 KB
Accession
0001179110-21-006842
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Award
Stock Option (right to purchase)
2021-06-14+20,000→ 20,000 totalExercise: $7.56Exp: 2031-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001564390
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:46 PM ET
- Size
- 5.4 KB